Blockchain Holdings Acquires COVID-19 Quarantine Tracker Already in Use in Hong Kong
Source: Streetwise Reports  (3/21/20)
The company anticipates adoption of the TRACEsafe system by other countries soon. More >

Bellerophon Shares Take Off as FDA Grants Emergency Expanded Access for INOpulse for COVID-19 Treatment
Source: Streetwise Reports  (3/20/20)
Shares of Bellerophon Therapeutics reached a new 52-week high price after the firm reported that the FDA granted emergency expanded access for its INOpulse® nitric oxide delivery system device for use in treatment of COVID-19 virus. More >

OPKO Health Partners with NY State Health Dept. to Create COVID-19 Drive-Thru Testing Facility
Source: Streetwise Reports  (3/13/20)
OPKO Health shares traded more than 30% higher after the company reported its subsidiary BioReference Laboratories has formed a partnership with the N.Y. State Department of Health to provide COVID-19 testing for the first public drive-through testing facility on the East Coast. More >

Predictive Oncology Launches AI Vaccine and Drug Platform & Acquires Technology
Source: Streetwise Reports  (3/12/20)
Shares of Predictive Oncology traded higher after the company reported that it launched a new AI vaccine and drug development platform targeting coronaviruses and acute respiratory syndromes and that it is acquiring Soluble Therapeutics assets including its HSC Technology. More >

Surgical Imaging Firm Reports Positive Physician Response to Bladder Cancer Visualization System
Source: Streetwise Reports  (3/11/20)
Imagin Medical announced on-going research feedback on its i/Blueâ„¢ Imaging System which allows simultaneous viewing of white and blue light images during bladder cancer resection procedures. More >

Vir Biotech Shares Rise on Joint Research Efforts with the NIH to Combat Coronaviruses
Source: Streetwise Reports  (3/11/20)
Vir Biotechnology shares traded higher after the company reported that it has entered into a research collaboration with the National Institutes of Health Vaccine Research Center on antibodies against coronaviruses including SARS-CoV-2. More >

Aytu Bio Shares Skyrocket After Gaining US Distribution Rights for Coronavirus Screening Test
Source: Streetwise Reports  (3/10/20)
Aytu BioScience shares rose by more than 750% at times today after the company reported that it secured an exclusive U.S. distribution agreement for COVID-19 point-of-care Rapid Test from a Hong Kong firm. More >

Enzo Biochem Shares Rise 60% as the Firm Commences COVID-19 Lab Testing
Source: Streetwise Reports  (3/6/20)
Shares of Enzo Biochem traded higher after the company advised that they will launch coronavirus testing services starting next week. More >

GenMark Shares Trade 30% Higher on Yearly Earnings and Increased SARS-CoV-2 Virus Detection Test Kit Shipments
Source: Streetwise Reports  (3/3/20)
Shares of GenMark Diagnostics traded higher after the firm reported FY/19 financial results and announced that it has increased global shipment of its test kits designed to detect the SARS-CoV-2 virus. More >

Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor
Source: Streetwise Reports  (2/26/20)
Shares of Nemaura Medical traded 20% higher after the firm reported that it is investigating using its non-invasive continuous glucose monitor sugarBEAT® jointly with its planned health subscription service BEAT®diabetes, to provide personalized lifestyle coaching for people with Type 2 diabetes and prediabetes. More >

Tech Firm Announces New Deals Worth $1 Million
Source: Streetwise Reports  (2/21/20)
These newly signed contracts of HealthSpace Data Systems are with governmental agencies in two U.S. states. More >

The 'Virus' Technology That Kills Coronavirus Plus Lots of Other Pathogens
Source: Fincom Investment Partners for Streetwise Reports  (2/18/20)
Fincom Investment Partners profiles TOMI Environmental Solutions, whose SteraMist disinfectant technology kills the coronavirus. More >

Myriad Genetics Shares Fall 30% on Q2 Earnings and Executive Leadership Change
Source: Streetwise Reports  (2/7/20)
Shares of Myriad Genetics traded 30% lower after the firm released Q2/20 earnings and announced the appointment of a new interim CEO. More >

Accuray Shares Rise on Q2 Earnings, Increased Backlog and Raised FY/20 EBITDA Guidance
Source: Streetwise Reports  (1/29/20)
Shares of Accuray traded 15% higher today after the company reported Q2/20 financial results. More >

Co-Diagnostics Utilizes CoPrimer Platform to Design New Coronavirus Detection Test
Source: Streetwise Reports  (1/23/20)
Molecular diagnostics company Co-Diagnostics' shares opened more than 144% higher after the firm reported it has designed a test for virus detection of the new coronavirus, 2019-nCoV, using its CoPrimerâ„¢ platform. More >

Disruptive Technology Poised to Deliver Significant Advancement in Bladder Cancer Detection
Source: Chris Temple for Streetwise Reports  (1/14/20)
Chris Temple, editor and publisher of The National Investor, explains why he recommends this small-cap as a Buy. More >

Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery
Source: Streetwise Reports  (1/14/20)
The disruptive technology is 'poised to deliver significant advancement in bladder cancer detection.' More >

Transenterix Shares Trade Up 25% on FDA Filing for First Machine Vision System in Robotic Surgery
Source: Streetwise Reports  (1/14/20)
Shares of Transenterix opened 50% higher after the company reported that it has submitted a 510(k) submission to the FDA for the first machine vision system for use in robotic surgery. More >

Adaptimmune Shares Triple as SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications
Source: Streetwise Reports  (1/13/20)
Shares of Adaptimmune Therapeutics more than tripled in value after the company reported that its SPEAR T-cell platform delivered positive initial responses in four different solid tumor indications. More >

Developer Completes Design Verification of Imaging Device for Bladder Cancer
Source: Streetwise Reports  (1/10/20)
In doing so, it gets one step closer to market approval from U.S. regulators. More >

Microbot Shares Soar on Claims It Has Created the World's First Fully Disposable Endovascular Robotic System
Source: Streetwise Reports  (12/24/19)
Shares of Microbot Medical traded 70% higher after the company reported that in January 2020 it will unveil the world's first fully disposable robotic system for endovascular procedures. The firm claims that its breakthrough technology features compact design, remote operation capabilities and an integrated "One & Done" tool to democratize endovascular procedures. More >

Reliq Re-establishes Itself as Community Care Technology Leader Amidst Sweeping Federal Medicare/Medicaid Changes
Source: Knox Henderson for Streetwise Reports  (11/13/19)
A shift in the industry leads to big new contracts and parabolic stock performance for this small cap. More >

Castle Biosciences Shares Storm Higher After Quadrupling Q3 YoY Revenue
Source: Streetwise Reports  (11/12/19)
Shares of melanoma and other skin cancers diagnostic firm Castle Biosciences Inc. traded more than 15% higher today after the firm announced Q3/19 financial and operational results. More >

Dexcom Posts 49% YoY Revenue Growth, Sending Shares to 52-Week High
Source: Streetwise Reports  (11/7/19)
Glucose monitoring systems developer Dexcom's shares traded 30% higher today after releasing Q3/19 earnings and raising full-year 2019 guidance. More >

Fulgent Genetics Hits 52-Week High After Posting 84% Q3 Revenue Increase
Source: Streetwise Reports  (11/5/19)
Fulgent Genetics shares traded more than 40% higher today after the company reported record revenue in Q3/19. The firm noted that it completed a record 20,697 billable tests in Q3/19, up 272% over the same period last year. More >